Brain cancer treatment shows promise in early trial
(HealthDay)—An experimental viral treatment may extend the lives of patients with a hard-to-treat brain cancer, researchers say.
Jun 1, 2016
0
235
(HealthDay)—An experimental viral treatment may extend the lives of patients with a hard-to-treat brain cancer, researchers say.
Jun 1, 2016
0
235
The fight against deadly forms of brain cancer, such as glioblastoma, could soon benefit from a major breakthrough, thanks to A*STAR researchers. The team has found a new link between cancer cell growth and its microenvironment.
May 6, 2016
0
26
An international research team has identified four likely new subtypes of a rare brain tumor using molecular techniques that lay the foundation for more accurate diagnosis and tailored therapies for the hard-to-treat cancer. ...
Feb 25, 2016
0
17
A research team, with the participation of the University of Granada (UGR), has made some progress in determining why glioblastoma multiforme (GBM), one of the most aggressive brain tumors known, is resistant to existing ...
Feb 17, 2016
0
327
Cancer is a mysterious disease for many reasons. Chief among the unknowns are how and why tumors form.
Jan 26, 2016
3
1166
(HealthDay)—Surgery that removes all visible cancer significantly improves the chances of survival for children with aggressive brain tumors, especially girls.
Sep 15, 2015
0
8
Drugs that target insulin pathways to slow or stop the growth of brain tumors are going in the right direction but appear to be on the wrong track, according to new research at Rice University.
Apr 20, 2015
0
6
Gliobststoma (GBM) is a highly aggressive brain tumor that is resistant to many conventional cancer therapies. The kinase mTOR induces pathways that are aberrantly activated in GBM. However, mTOR inhibitors have not shown ...
Mar 23, 2015
0
7
A somatic mutation in the ATRX gene has recently been shown as a potential molecular marker for aggressive brain tumors, such as gliomas, neuroblastomas and pancreatic neuroendocrine tumors. Now, for the first time, researchers ...
Jan 21, 2015
0
45
Research led by the Vall d'Hebron Institute of Oncology (VHIO) evidence the most conclusive preclinical results to-date validating Myc inhibition as a therapeutic strategy in glioma – a highly agressive tumor type that ...
Aug 18, 2014
0
0